197 related articles for article (PubMed ID: 18240958)
1. Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.
Giancola ML; Rizzi EB; Lorenzini P; Rovighi L; Baldini F; Schininà V; Larussa D; Bibbolino C; Antinori A
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):155-62. PubMed ID: 18240958
[TBL] [Abstract][Full Text] [Related]
2. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
[TBL] [Abstract][Full Text] [Related]
3. Clinical Profile and Outcome of Progressive Multifocal Leukoencephalopathy in HIV Infected Indian Patients.
Shah V; Toshniwal H; Shevkani M
J Assoc Physicians India; 2017 Mar; 65(3):40-44. PubMed ID: 28462542
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
[TBL] [Abstract][Full Text] [Related]
5. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
[TBL] [Abstract][Full Text] [Related]
6. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.
De Luca A; Giancola ML; Ammassari A; Grisetti S; Cingolani A; Paglia MG; Govoni A; Murri R; Testa L; Monforte AD; Antinori A
AIDS; 2000 Sep; 14(14):F117-21. PubMed ID: 11061646
[TBL] [Abstract][Full Text] [Related]
7. Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
Wyen C; Hoffmann C; Schmeisser N; Wöhrmann A; Qurishi N; Rockstroh J; Esser S; Rieke A; Ross B; Lorenzen T; Schmitz K; Stenzel W; Salzberger B; Fätkenheuer G
J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1263-8. PubMed ID: 15385733
[TBL] [Abstract][Full Text] [Related]
8. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
[TBL] [Abstract][Full Text] [Related]
9. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy.
Miralles P; Berenguer J; García de Viedma D; Padilla B; Cosin J; López-Bernaldo de Quirós JC; Muñoz L; Moreno S; Bouza E
AIDS; 1998 Dec; 12(18):2467-72. PubMed ID: 9875585
[TBL] [Abstract][Full Text] [Related]
10. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.
Albrecht H; Hoffmann C; Degen O; Stoehr A; Plettenberg A; Mertenskötter T; Eggers C; Stellbrink HJ
AIDS; 1998 Jul; 12(10):1149-54. PubMed ID: 9677163
[TBL] [Abstract][Full Text] [Related]
11. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
12. [Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?].
Montes Santiago J; Pérez Fernández E; González Vázquez L; Morano Amado L; Fernández Martín J; Asorey Carballeira A; Pérez Alvarez R
An Med Interna; 2002 May; 19(5):230-3. PubMed ID: 12107996
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients.
Huang D; Cossoy M; Li M; Choi D; Taege A; Staugaitis SM; Rehm S; Ransohoff RM
Ann Neurol; 2007 Jul; 62(1):34-9. PubMed ID: 17328067
[TBL] [Abstract][Full Text] [Related]
14. Evolution of purely infratentorial PML under HAART--negative outcome under rapid immune reconstitution.
Kastrup O; Wanke I; Esser S; Maschke M
Clin Neurol Neurosurg; 2005 Oct; 107(6):509-13. PubMed ID: 16202824
[TBL] [Abstract][Full Text] [Related]
15. The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature.
Cinque P; Bossolasco S; Brambilla AM; Boschini A; Mussini C; Pierotti C; Campi A; Casari S; Bertelli D; Mena M; Lazzarin A
J Neurovirol; 2003; 9 Suppl 1():73-80. PubMed ID: 12709876
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.
Antinori A; Ammassari A; Giancola ML; Cingolani A; Grisetti S; Murri R; Alba L; Ciancio B; Soldani F; Larussa D; Ippolito G; De Luca A
J Neurovirol; 2001 Aug; 7(4):323-8. PubMed ID: 11517411
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy in an HIV patient receiving successful long-term HAART.
Mascarello M; Lanzafame M; Lattuada E; Concia E; Ferrari S
J Neurovirol; 2011 Apr; 17(2):196-9. PubMed ID: 21445699
[TBL] [Abstract][Full Text] [Related]
18. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.
Gasnault J; Taoufik Y; Goujard C; Kousignian P; Abbed K; Boue F; Dussaix E; Delfraissy JF
J Neurovirol; 1999 Aug; 5(4):421-9. PubMed ID: 10463864
[TBL] [Abstract][Full Text] [Related]
19. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
20. Atypical progressive multifocal leukoencephalopathy in HIV with a high CD4 count: the use of magnetic resonance imaging plus spectrometry studies.
Manfredi R; Piergentili B; Marinacci G; Calza L
Int J STD AIDS; 2012 Mar; 23(3):e35-8. PubMed ID: 22581894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]